Company profile: Fabric Genomics
1.1 - Company Overview
Company description
- Provider of genomics-driven precision medicine software, delivering end-to-end genomic analysis, interpretation, and clinical reporting for clinical labs, hospital systems, and country-sequencing programs. Powers actionable genomic insights to enable faster, more accurate diagnoses, featuring AI algorithms including GEM, VAAST, and Phevor for disease gene and phenotype-driven variant ranking.
Products and services
- GEM: AI-driven algorithm for disease gene ranking that enhances diagnostic yield in genomic data analysis for clinical labs, hospital systems, and country-sequencing programs
- Fabric Enterprise: Clinical-grade comprehensive platform for NGS analysis, interpretation, and clinical reporting that delivers end-to-end genomic analysis with AI-powered genomic insights, enabling faster diagnoses and reduced turnaround time
- Phevor: Phenotype-driven algorithm for prioritization of genomic variants that facilitates accurate diagnosis in genomics-driven precision medicine and clinical decision support contexts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Fabric Genomics
Chromatin
HQ: United States
Website
- Description: Provider of plant breeding and genomics technologies for agricultural, energy, chemical, nutritional and pharmaceutical sectors. Develops sorghum for agriculture and renewable energy, and advances maize and wheat via high-yielding, disease- and climate-resilient traits. Services include genomic selection, high-throughput phenotyping, multi-trait analysis, environics for genotype prediction, and integrated genomics-phenomics modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chromatin company profile →
Bluebird Bio
HQ: United States
Website
- Description: Provider of gene therapies for severe genetic and rare diseases, developing gene addition treatments that modify patient cells to address underlying genetic causes using lentiviral vectors. Products include LentiGlobin for sickle cell disease, Lenti-D for cerebral adrenoleukodystrophy, and Zynteglo for beta-thalassemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bluebird Bio company profile →
Vigene Biosciences
HQ: United States
Website
- Description: Provider of gene delivery technologies and cell and gene therapy CDMO solutions, offering research- and cGMP-grade AAV, lentivirus, and adenovirus products and custom services, including ready-to-ship genome-wide human cDNA ORFs on adenoviral or lentiviral, supporting therapy development and production to advance biomedical research and make gene therapy affordable.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vigene Biosciences company profile →
Arrakis Therapeutics
HQ: United States
Website
- Description: Provider of RNA-targeted drug discovery tools and small-molecule therapeutics, including the rSM Toolkit to identify RNA substructures, Direct Modulators that bind RNA, Targeted RNA Degraders, and Covalent Modifiers that block translation. Maintains pipeline programs for cancer, cardiovascular conditions, neurodegeneration, and rare diseases, including an rSM program for DM1.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrakis Therapeutics company profile →
Automated Lab Solutions
HQ: Germany
Website
- Description: Provider of life science robotics and automation, including the CellCelector automated system for fluorescence imaging, selection, and image-based sorting/picking of single cells, clusters, adherent cell colonies, and clones from semi-solid media; rare single cell isolation; single cell cloning; stem cell picking; the Incubator FlowBox laminar flow cabinet; and automation components.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Automated Lab Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Fabric Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Fabric Genomics
2.2 - Growth funds investing in similar companies to Fabric Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Fabric Genomics
4.2 - Public trading comparable groups for Fabric Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →